NASDAQ
Intellia Therapeutics, Inc. (NTLA) has a current ratio of 5.08x as of Tuesday, May 26, 2026. This represents a 32.64% decrease compared to its 12-month average of 7.54x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.